RTW INVESTMENTS, LP
Filing Date
Global Rank
#414
/ 8,603
▲ 10
· as of Mar 2026
Top Industry
Biotechnology
82.2%
3Y Alpha vs SPY
-4.1%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+56.4%
SPY
+76.5%
Annualised alpha
-4.8%
Max drawdown
−29.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
87 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
10.4%
−1.2 pts
Top 5
34.0%
−2.0 pts
Top 10
50.0%
−0.3 pts
HHI
373
Diversified−20
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.9% | $10,041,600,134 |
| Financial Services | 0.1% | $8,145,225 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ERAS | Erasca, Inc. | +16,010,524 | 16,157,175 | $261,423,091 | |
| TNGX | Tango Therapeutics, Inc. | +11,809,392 | 13,300,620 | $278,248,970 | |
| CGON | CG Oncology, Inc. | +4,972,681 | 6,984,808 | $472,731,805 | |
| MIST | Milestone Pharmaceuticals Inc. | +3,824,899 | 6,331,001 | $7,533,891 | |
| CELC | Celcuity Inc. | +2,489,461 | 3,039,621 | $346,942,340 | |
| CMPS | COMPASS Pathways plc | +1,875,000 | 10,632,390 | $58,797,116 | |
| CMPX | Compass Therapeutics, Inc. | +1,686,599 | 4,186,599 | $22,147,108 | |
| HNGE | Hinge Health, Inc. | +1,576,500 | 1,930,000 | $74,420,800 | |
| IMTX | Immatics N.V. | +1,435,986 | 12,869,340 | $126,634,305 | |
| AQST | Aquestive Therapeutics, Inc. | +1,176,471 | 7,426,471 | $30,819,854 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +648,656 | 3,648,795 | $76,442,255 | |
| CSTL | Castle Biosciences Inc | +643,098 | 2,758,335 | $67,717,124 | |
| FLGT | Fulgent Genetics, Inc. | +583,973 | 1,289,000 | $20,495,100 | |
| IRTC | iRhythm Holdings, Inc. | +486,510 | 1,668,500 | $196,916,370 | |
| RDNT | RadNet, Inc. | +346,500 | 4,285,000 | $239,488,650 | |
| CNTA | Centessa Pharmaceuticals plc | +263,338 | 2,054,175 | $81,591,831 | |
| EVMN | Evommune, Inc. | +218,564 | 1,502,235 | $34,536,382 | |
| REPL | Replimune Group, Inc. | +216,564 | 7,356,916 | $56,280,407 | |
| RGEN | Repligen Corp | +142,000 | 1,206,000 | $142,090,920 | |
| ISRG | Intuitive Surgical Inc | +118,772 | 220,000 | $101,417,800 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | +100,000 | 1,451,326 | $52,712,160 | |
| STOK | Stoke Therapeutics, Inc. | +76,669 | 5,623,525 | $183,101,974 | |
| APGE | Apogee Therapeutics, Inc. | +70,000 | 2,782,097 | $234,169,104 | |
| ESTA | Establishment Labs Holdings Inc. | +66,864 | 2,655,695 | $150,790,362 | |
| ARGX | Argenx SE | +35,949 | 709,446 | $518,072,941 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | −3,981,719 | 3,685,045 | $148,249,360 | |
| TSHA | Taysha Gene Therapies, Inc. | −2,718,049 | 13,680,248 | $61,150,708 | |
| COGT | Cogent Biosciences, Inc. | −2,133,566 | 5,458,675 | $210,104,400 | |
| LRMR | Larimar Therapeutics, Inc. | −1,625,000 | 1,500,000 | $6,750,000 | |
| QURE | uniQure N.V. | −1,125,106 | 2,586,356 | $42,286,920 | |
| JBIO | Jade Biosciences, Inc. | −876,068 | 573,205 | $8,053,530 | |
| BBNX | Beta Bionics, Inc. | −500,000 | 2,000,000 | $20,040,000 | |
| XGN | Exagen Inc. | −395,231 | 395,231 | $1,185,693 | |
| ZLAB | Zai Lab Ltd | −385,000 | 6,574,032 | $123,657,541 | |
| NTRA | Natera, Inc. | −250,000 | 1,250,000 | $249,987,500 | |
| SYK | Stryker Corp | −145,000 | 100,000 | $32,859,000 | |
| TENX | Tenax Therapeutics, Inc. | −8,100 | 370,246 | $5,920,233 | |
| IMVT | Immunovant, Inc. | −1 | 3,177,849 | $78,937,769 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| WAY | Waystar Holding Corp. | 1,630,000 | $39,299,300 | |
| CADL | Candel Therapeutics, Inc. | 6,422,018 | $31,467,888 | |
| AKTS | Aktis Oncology, Inc. | 1,592,043 | $28,481,649 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 248,063 | $20,817,446 | |
| IPSC | Century Therapeutics, Inc. | 8,695,652 | $19,652,173 | |
| AVTX | Avalo Therapeutics, Inc. | 856,962 | $12,794,442 | |
| OCGN | Ocugen, Inc. | 6,666,666 | $12,066,665 | |
| ATAI | AtaiBeckley Inc. | 2,000,000 | $7,080,000 | |
| DFTX | Definium Therapeutics, Inc. | 300,000 | $5,670,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PEN | Penumbra Inc | 866,499 | $269,403,204 | |
| AXSM | Axsome Therapeutics, Inc. | 888,001 | $162,184,502 | |
| ALUR | Allurion Technologies, Inc. | 5,891,430 | $108,696,883 | |
| PODD | Insulet Corp | 324,600 | $92,264,304 | |
| MASI | Masimo Corp | 683,294 | $88,869,217 | |
| TEM | Tempus AI, Inc. | 200,000 | $11,810,000 | |
| IQV | Iqvia Holdings Inc. | 46,000 | $10,368,860 | |
| GPCR | Structure Therapeutics Inc. | 100,000 | $6,955,000 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 447,607 | $3,446,573 | |
| No positions match the current search. | ||||
87 positions ·
$10,049,745,359 total
· as of Mar 31, 2026
Showing 1–50
of 87 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Held | 1,993,687 | $1,043,635,333 | 10.38% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 4,842,880 | $791,907,737 | 7.88% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 5,059,053 | $533,224,186 | 5.31% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Held | 7,746,415 | $527,763,253 | 5.25% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 709,446 | $518,072,941 | 5.16% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Added | 6,984,808 | $472,731,805 | 4.70% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 3,039,621 | $346,942,340 | 3.45% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 13,300,620 | $278,248,970 | 2.77% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 16,157,175 | $261,423,091 | 2.60% | |
| NTRA |
Natera, Inc.
Healthcare
|
Reduced | 1,250,000 | $249,987,500 | 2.49% | |
| RDNT |
RadNet, Inc.
Healthcare
|
Added | 4,285,000 | $239,488,650 | 2.38% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 3,346,025 | $234,723,653 | 2.34% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 2,782,097 | $234,169,104 | 2.33% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Held | 4,171,996 | $210,435,478 | 2.09% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 5,458,675 | $210,104,400 | 2.09% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 1,668,500 | $196,916,370 | 1.96% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Added | 5,623,525 | $183,101,974 | 1.82% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 2,721,158 | $179,351,523 | 1.78% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Held | 7,144,524 | $159,037,104 | 1.58% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
Added | 2,655,695 | $150,790,362 | 1.50% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 3,685,045 | $148,249,360 | 1.48% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Held | 4,869,798 | $146,824,409 | 1.46% | |
| RGEN |
Repligen Corp
Healthcare
|
Added | 1,206,000 | $142,090,920 | 1.41% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 1,062,072 | $139,917,365 | 1.39% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Held | 1,481,033 | $136,803,018 | 1.36% | |
| IMTX |
Immatics N.V.
Healthcare
|
Added | 12,869,340 | $126,634,305 | 1.26% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Reduced | 6,574,032 | $123,657,541 | 1.23% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Held | 715,332 | $114,052,534 | 1.13% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Added | 220,000 | $101,417,800 | 1.01% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Held | 2,058,148 | $100,952,159 | 1.00% | |
| GHRS |
GH Research PLC
Healthcare
|
Held | 5,933,815 | $83,429,438 | 0.83% | |
| XNCR |
Xencor Inc
Healthcare
|
Held | 6,777,461 | $81,736,179 | 0.81% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Held | 4,543,895 | $81,699,232 | 0.81% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 2,054,175 | $81,591,831 | 0.81% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 3,177,849 | $78,937,769 | 0.79% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 3,648,795 | $76,442,255 | 0.76% | |
| HNGE |
Hinge Health, Inc.
Healthcare
|
Added | 1,930,000 | $74,420,800 | 0.74% | |
| CSTL |
Castle Biosciences Inc
Healthcare
|
Added | 2,758,335 | $67,717,124 | 0.67% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Held | 17,687,772 | $63,322,223 | 0.63% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Reduced | 13,680,248 | $61,150,708 | 0.61% | |
| ALKS |
Alkermes plc.
Healthcare
|
Held | 1,672,356 | $59,134,508 | 0.59% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Added | 10,632,390 | $58,797,116 | 0.59% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Added | 1,487,934 | $56,720,044 | 0.56% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Added | 7,356,916 | $56,280,407 | 0.56% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Added | 1,451,326 | $52,712,160 | 0.52% | |
| QURE |
uniQure N.V.
Healthcare
|
Reduced | 2,586,356 | $42,286,920 | 0.42% | |
| WAY |
Waystar Holding Corp.
Healthcare
|
NEW | 1,630,000 | $39,299,300 | 0.39% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 585,682 | $36,722,261 | 0.37% | |
| OBIO |
Orchestra BioMed Holdings, Inc.
Healthcare
|
Held | 8,306,063 | $35,300,767 | 0.35% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Held | 6,576,306 | $34,854,421 | 0.35% |